Mortalin expression in pancreatic cancer and its clinical and prognostic significance

Xuelian Cui, Zhenling Li, Junjie Piao, Jinzi Li, Longshan Li, Zhenhua Lin, Aihua Jin

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Mortalin, an essential mitochondrial chaperone protein, is involved in the tumorigenesis of a number of malignancies. This study aimed to investigate the expression of Mortalin in pancreatic ductal adenocarcinoma (PDAC) cells and to determine its clinicopathological and prognostic significance. The localization of Mortalin protein was detected in BXPC-3 PDAC cells using immunofluorescence. Immunohistochemistry was also used to detect Mortalin expression in well-defined tissues obtained from 106 PDAC patients and 46 corresponding nontumor pancreatic tissues. Clinicopathological parameters and overall survival data were collected and compared between different Mortalin statuses. The results of immunohistochemistry and immunofluorescence showed that Mortalin was primarily present in the cytoplasm of PDAC cells. The ratio of strong positive staining for Mortalin was higher in PDAC tissues (55.66%; 59/106) than in normal adjacent tissues (23.91%; 11/46). Positive relationships between Mortalin expression and clinical stage, perineural invasion, lymph node metastasis, and lower overall survival were observed. Multivariate Cox regression analysis identified Mortalin as a significant independent prognostic factor, in addition to location, clinical stage, and perineural invasion, for survival of PDAC patients. Therefore, we present strong evidence that Mortalin may function as a practical marker to predict prognosis and as a potential therapeutic target in PDAC treatment.

Original languageEnglish (US)
Pages (from-to)171-178
Number of pages8
JournalHuman Pathology
Volume64
DOIs
StatePublished - Jun 1 2017

Fingerprint

Pancreatic Neoplasms
Adenocarcinoma
Fluorescent Antibody Technique
Survival
Immunohistochemistry
mortalin
Mitochondrial Proteins
Carcinogenesis
Cytoplasm
Lymph Nodes
Regression Analysis
Staining and Labeling
Neoplasm Metastasis
Therapeutics

Keywords

  • Biomarker
  • Mortalin
  • Pancreatic ductal adenocarcinoma
  • Prognosis
  • Survival analysis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Mortalin expression in pancreatic cancer and its clinical and prognostic significance. / Cui, Xuelian; Li, Zhenling; Piao, Junjie; Li, Jinzi; Li, Longshan; Lin, Zhenhua; Jin, Aihua.

In: Human Pathology, Vol. 64, 01.06.2017, p. 171-178.

Research output: Contribution to journalArticle

Cui, Xuelian ; Li, Zhenling ; Piao, Junjie ; Li, Jinzi ; Li, Longshan ; Lin, Zhenhua ; Jin, Aihua. / Mortalin expression in pancreatic cancer and its clinical and prognostic significance. In: Human Pathology. 2017 ; Vol. 64. pp. 171-178.
@article{453dad3e3c614317abb47546e806c75f,
title = "Mortalin expression in pancreatic cancer and its clinical and prognostic significance",
abstract = "Mortalin, an essential mitochondrial chaperone protein, is involved in the tumorigenesis of a number of malignancies. This study aimed to investigate the expression of Mortalin in pancreatic ductal adenocarcinoma (PDAC) cells and to determine its clinicopathological and prognostic significance. The localization of Mortalin protein was detected in BXPC-3 PDAC cells using immunofluorescence. Immunohistochemistry was also used to detect Mortalin expression in well-defined tissues obtained from 106 PDAC patients and 46 corresponding nontumor pancreatic tissues. Clinicopathological parameters and overall survival data were collected and compared between different Mortalin statuses. The results of immunohistochemistry and immunofluorescence showed that Mortalin was primarily present in the cytoplasm of PDAC cells. The ratio of strong positive staining for Mortalin was higher in PDAC tissues (55.66{\%}; 59/106) than in normal adjacent tissues (23.91{\%}; 11/46). Positive relationships between Mortalin expression and clinical stage, perineural invasion, lymph node metastasis, and lower overall survival were observed. Multivariate Cox regression analysis identified Mortalin as a significant independent prognostic factor, in addition to location, clinical stage, and perineural invasion, for survival of PDAC patients. Therefore, we present strong evidence that Mortalin may function as a practical marker to predict prognosis and as a potential therapeutic target in PDAC treatment.",
keywords = "Biomarker, Mortalin, Pancreatic ductal adenocarcinoma, Prognosis, Survival analysis",
author = "Xuelian Cui and Zhenling Li and Junjie Piao and Jinzi Li and Longshan Li and Zhenhua Lin and Aihua Jin",
year = "2017",
month = "6",
day = "1",
doi = "10.1016/j.humpath.2017.03.015",
language = "English (US)",
volume = "64",
pages = "171--178",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Mortalin expression in pancreatic cancer and its clinical and prognostic significance

AU - Cui, Xuelian

AU - Li, Zhenling

AU - Piao, Junjie

AU - Li, Jinzi

AU - Li, Longshan

AU - Lin, Zhenhua

AU - Jin, Aihua

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Mortalin, an essential mitochondrial chaperone protein, is involved in the tumorigenesis of a number of malignancies. This study aimed to investigate the expression of Mortalin in pancreatic ductal adenocarcinoma (PDAC) cells and to determine its clinicopathological and prognostic significance. The localization of Mortalin protein was detected in BXPC-3 PDAC cells using immunofluorescence. Immunohistochemistry was also used to detect Mortalin expression in well-defined tissues obtained from 106 PDAC patients and 46 corresponding nontumor pancreatic tissues. Clinicopathological parameters and overall survival data were collected and compared between different Mortalin statuses. The results of immunohistochemistry and immunofluorescence showed that Mortalin was primarily present in the cytoplasm of PDAC cells. The ratio of strong positive staining for Mortalin was higher in PDAC tissues (55.66%; 59/106) than in normal adjacent tissues (23.91%; 11/46). Positive relationships between Mortalin expression and clinical stage, perineural invasion, lymph node metastasis, and lower overall survival were observed. Multivariate Cox regression analysis identified Mortalin as a significant independent prognostic factor, in addition to location, clinical stage, and perineural invasion, for survival of PDAC patients. Therefore, we present strong evidence that Mortalin may function as a practical marker to predict prognosis and as a potential therapeutic target in PDAC treatment.

AB - Mortalin, an essential mitochondrial chaperone protein, is involved in the tumorigenesis of a number of malignancies. This study aimed to investigate the expression of Mortalin in pancreatic ductal adenocarcinoma (PDAC) cells and to determine its clinicopathological and prognostic significance. The localization of Mortalin protein was detected in BXPC-3 PDAC cells using immunofluorescence. Immunohistochemistry was also used to detect Mortalin expression in well-defined tissues obtained from 106 PDAC patients and 46 corresponding nontumor pancreatic tissues. Clinicopathological parameters and overall survival data were collected and compared between different Mortalin statuses. The results of immunohistochemistry and immunofluorescence showed that Mortalin was primarily present in the cytoplasm of PDAC cells. The ratio of strong positive staining for Mortalin was higher in PDAC tissues (55.66%; 59/106) than in normal adjacent tissues (23.91%; 11/46). Positive relationships between Mortalin expression and clinical stage, perineural invasion, lymph node metastasis, and lower overall survival were observed. Multivariate Cox regression analysis identified Mortalin as a significant independent prognostic factor, in addition to location, clinical stage, and perineural invasion, for survival of PDAC patients. Therefore, we present strong evidence that Mortalin may function as a practical marker to predict prognosis and as a potential therapeutic target in PDAC treatment.

KW - Biomarker

KW - Mortalin

KW - Pancreatic ductal adenocarcinoma

KW - Prognosis

KW - Survival analysis

UR - http://www.scopus.com/inward/record.url?scp=85019970695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019970695&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2017.03.015

DO - 10.1016/j.humpath.2017.03.015

M3 - Article

C2 - 28412209

AN - SCOPUS:85019970695

VL - 64

SP - 171

EP - 178

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

ER -